| Authors: |
Hendriks MP; Department of Health Technology and Services Research, Technical Medical Center, University of Twente, PO Box 217, 7500 AE Enschede, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB Utrecht, the Netherlands; Department of Medical Oncology, Northwest Clinics, PO Box 501, 1800 AM Alkmaar, the Netherlands. Electronic address: m.p.hendriks@nwz.nl., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000 CA Rotterdam, the Netherlands. Electronic address: a.jager@erasmusmc.nl., Ebben KCWJ; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB Utrecht, the Netherlands. Electronic address: k.ebben@iknl.nl., van Til JA; Department of Health Technology and Services Research, Technical Medical Center, University of Twente, PO Box 217, 7500 AE Enschede, the Netherlands. Electronic address: j.a.vantil@utwente.nl., Siesling S; Department of Health Technology and Services Research, Technical Medical Center, University of Twente, PO Box 217, 7500 AE Enschede, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB Utrecht, the Netherlands. Electronic address: s.siesling@utwente.nl. |
